GRDN Guardian Pharmacy Services, Inc.
NYSE · SEC CIK 1802255 · EDGAR
- Bought, last 12 months
- $99.8K 1 purchases by 1 insiders
- Sold, last 12 months
- $419.22M 9 sales by 9 insiders
- Filings on record
- 66 since 2024-10-01, latest 2026-05-07 16:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Bindley Capital Partners I, LLC | 10% | — | $105.98M |
| Salentine Thomas J Jr | Dir, 10% | — | $105.98M |
| BINDLEY WILLIAM E | Dir, 10% | — | $105.98M |
| Ackerman John | Dir | — | $32.75M |
| Pharmacy Investors, LLC | Member of 10% owner group | — | $24.56M |
| Burke Fred | See Remarks, Dir | — | $19.93M |
| Forbes Kendall | See Remarks | — | $10.29M |
| Cardinal Equity Fund, L.P. | Member of 10% owner group | — | $8.18M |
| Morris David K | See Remarks, Dir | — | $5.58M |
| COSLER STEVEN D | Dir | $99.8K | — |
Transactions 63
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 16:20 | 2026-05-05 | GRDN | COSLER STEVEN D | Dir | A - Grant | $0.00 | +4,028 | 29.0K | +16% | $0 | |
| 2026-05-07 16:20 | 2026-05-05 | GRDN | LEWIS RANDALL J | Dir | A - Grant | $0.00 | +4,028 | 15.1K | +36% | $0 | |
| 2026-05-07 16:20 | 2026-05-05 | GRDN | Patchett Mary Sue | Dir | A - Grant | $0.00 | +4,028 | 15.1K | +36% | $0 | |
| DMI | 2026-03-31 | 2026-03-28 | GRDN | Ackerman John | Dir | M - OptEx | — | +1.88M | 816.2K | New | — |
| DI | 2026-03-31 | 2026-03-28 | GRDN | Salentine Thomas J Jr | Dir, 10% | M - OptEx | — | +6.10M | 10.57M | +136% | — |
| D | 2026-03-31 | 2026-03-28 | GRDN | Morris David K | See Remarks, Dir | M - OptEx | — | +641.9K | 896.3K | +252% | — |
| D | 2026-03-31 | 2026-03-28 | GRDN | Bindley Capital Partners I, LLC | 10% | M - OptEx | — | +6.10M | 10.57M | +136% | — |
| DI | 2026-03-31 | 2026-03-28 | GRDN | BINDLEY WILLIAM E | Dir, 10% | M - OptEx | — | +6.10M | 10.57M | +136% | — |
| D | 2026-03-31 | 2026-03-28 | GRDN | Forbes Kendall | See Remarks | M - OptEx | — | +608.6K | 1.06M | +134% | — |
| D | 2026-03-31 | 2026-03-28 | GRDN | Cardinal Equity Fund, L.P. | Member of 10% owner group | M - OptEx | — | +471.1K | 816.2K | +136% | — |
| D | 2026-03-31 | 2026-03-28 | GRDN | Pharmacy Investors, LLC | Member of 10% owner group | M - OptEx | — | +1.41M | 2.45M | +136% | — |
| D | 2026-03-31 | 2026-03-28 | GRDN | Burke Fred | See Remarks, Dir | M - OptEx | — | +1.30M | 2.14M | +155% | — |
| I | 2026-03-24 | 2026-03-20 | GRDN | BINDLEY WILLIAM E | Dir, 10% | S - Sale | $29.68 | -3.57M | 4.47M | -44% | -$105.98M |
| 2026-03-24 | 2026-03-20 | GRDN | Bindley Capital Partners I, LLC | 10% | S - Sale | $29.68 | -3.57M | 4.47M | -44% | -$105.98M | |
| I | 2026-03-24 | 2026-03-20 | GRDN | Salentine Thomas J Jr | Dir, 10% | S - Sale | $29.68 | -3.57M | 4.47M | -44% | -$105.98M |
| 2026-03-24 | 2026-03-20 | GRDN | Forbes Kendall | See Remarks | S - Sale | $29.68 | -346.7K | 453.3K | -43% | -$10.29M | |
| MI | 2026-03-24 | 2026-03-20 | GRDN | Ackerman John | Dir | S - Sale | $29.68 | -1.10M | 1.04M | -52% | -$32.75M |
| 2026-03-24 | 2026-03-20 | GRDN | Morris David K | See Remarks, Dir | S - Sale | $29.68 | -187.9K | 254.5K | -42% | -$5.58M | |
| 2026-03-24 | 2026-03-20 | GRDN | Burke Fred | See Remarks, Dir | S - Sale | $29.68 | -671.4K | 840.4K | -44% | -$19.93M | |
| 2026-03-24 | 2026-03-20 | GRDN | Pharmacy Investors, LLC | Member of 10% owner group | S - Sale | $29.68 | -827.6K | 1.04M | -44% | -$24.56M | |
| 2026-03-24 | 2026-03-20 | GRDN | Cardinal Equity Fund, L.P. | Member of 10% owner group | S - Sale | $29.68 | -275.7K | 345.1K | -44% | -$8.18M | |
| 2026-03-03 | 2026-03-01 | GRDN | Morris David K | See Remarks, Dir | A - Grant | $0.00 | +8,952 | 442.3K | +2% | $0 | |
| 2026-03-03 | 2026-03-01 | GRDN | Forbes Kendall | See Remarks | A - Grant | $0.00 | +8,952 | 799.9K | +1% | $0 | |
| 2025-12-08 | 2025-12-04 | GRDN | Forbes Kendall | See Remarks | G - Gift | $0.00 | -21.5K | 791.0K | -3% | $0 | |
| 2025-12-08 | 2025-12-04 | GRDN | Burke Fred | See Remarks, Dir | G - Gift | $0.00 | -200.0K | 1.51M | -12% | $0 | |
| 2025-12-05 | 2025-12-03 | GRDN | COSLER STEVEN D | Dir | P - Purchase | $29.61 | +3,370 | 25.0K | +16% | +$99.8K | |
| D | 2025-09-30 | 2025-09-27 | GRDN | Morris David K | See Remarks, Dir | M - OptEx | — | +641.9K | 856.4K | +299% | — |
| DI | 2025-09-30 | 2025-09-27 | GRDN | BINDLEY WILLIAM E | Dir, 10% | M - OptEx | — | +6.10M | 8.04M | +314% | — |
| DI | 2025-09-30 | 2025-09-27 | GRDN | Salentine Thomas J Jr | Dir, 10% | M - OptEx | — | +6.10M | 8.04M | +314% | — |
| D | 2025-09-30 | 2025-09-27 | GRDN | Burke Fred | See Remarks, Dir | M - OptEx | — | +1.30M | 1.71M | +314% | — |
| D | 2025-09-30 | 2025-09-27 | GRDN | Forbes Kendall | See Remarks | M - OptEx | — | +608.6K | 812.5K | +298% | — |
| DMI | 2025-09-30 | 2025-09-27 | GRDN | Ackerman John | Dir | M - OptEx | — | +1.88M | 620.9K | New | — |
| D | 2025-09-30 | 2025-09-27 | GRDN | Pharmacy Investors, LLC | Member of 10% owner group | M - OptEx | — | +1.41M | 1.86M | +314% | — |
| DM | 2025-09-30 | 2025-05-27+ | GRDN | Pharmacy Investors, LLC | Member of 10% owner group | S - Sale+OE | $20.16 | -964.3K | 600.6K | -62% | -$19.44M |
| DM | 2025-09-30 | 2025-05-27+ | GRDN | Cardinal Equity Fund, L.P. | Member of 10% owner group | S - Sale+OE | $20.16 | -321.3K | 200.1K | -62% | -$6.48M |
| D | 2025-09-30 | 2025-09-27 | GRDN | Cardinal Equity Fund, L.P. | Member of 10% owner group | M - OptEx | — | +471.1K | 620.9K | +314% | — |
| D | 2025-09-30 | 2025-09-27 | GRDN | Bindley Capital Partners I, LLC | 10% | M - OptEx | — | +6.10M | 8.04M | +314% | — |
| M | 2025-05-29 | 2025-05-27+ | GRDN | Forbes Kendall | See Remarks | S - Sale | $20.16 | -415.0K | 203.9K | -67% | -$8.37M |
| M | 2025-05-29 | 2025-05-27+ | GRDN | Bindley Capital Partners I, LLC | 10% | S - Sale | $20.16 | -4.16M | 2.59M | -62% | -$83.87M |
| MI | 2025-05-29 | 2025-05-27+ | GRDN | BINDLEY WILLIAM E | Dir, 10% | S - Sale | $20.16 | -4.16M | 1.94M | -68% | -$83.87M |
| MI | 2025-05-29 | 2025-05-27+ | GRDN | Ackerman John | Dir | S - Sale | $20.16 | -1.29M | 149.8K | -90% | -$25.92M |
| MI | 2025-05-29 | 2025-05-27+ | GRDN | Salentine Thomas J Jr | Dir, 10% | S - Sale | $20.16 | -4.16M | 1.94M | -68% | -$83.87M |
| M | 2025-05-29 | 2025-05-27+ | GRDN | Morris David K | See Remarks, Dir | S - Sale | $20.16 | -437.8K | 214.5K | -67% | -$8.83M |
| M | 2025-05-29 | 2025-05-27+ | GRDN | Burke Fred | See Remarks, Dir | S - Sale | $20.16 | -885.8K | 551.7K | -62% | -$17.86M |
| 2025-05-12 | 2025-05-09 | GRDN | LEWIS RANDALL J | Dir | A - Grant | $0.00 | +3,901 | 11.0K | +55% | $0 | |
| 2025-05-12 | 2025-05-09 | GRDN | Patchett Mary Sue | Dir | A - Grant | $0.00 | +3,901 | 11.0K | +55% | $0 | |
| 2025-05-12 | 2025-05-09 | GRDN | COSLER STEVEN D | Dir | A - Grant | $0.00 | +3,901 | 21.6K | +22% | $0 | |
| DI | 2025-04-01 | 2025-03-28 | GRDN | BINDLEY WILLIAM E | Dir, 10% | M - OptEx | — | +6.10M | 6.10M | New | — |
| DMI | 2025-04-01 | 2025-03-28 | GRDN | Ackerman John | Dir | M - OptEx | — | +1.88M | 471.1K | New | — |
| DI | 2025-04-01 | 2025-03-28 | GRDN | Salentine Thomas J Jr | Dir | M - OptEx | — | +6.10M | 6.10M | New | — |
| D | 2025-04-01 | 2025-03-28 | GRDN | Morris David K | See Remarks, Dir | M - OptEx | — | +641.9K | 652.3K | +6,181% | — |
| D | 2025-04-01 | 2025-03-28 | GRDN | Forbes Kendall | See Remarks | M - OptEx | — | +608.6K | 619.0K | +5,860% | — |
| D | 2025-04-01 | 2025-03-28 | GRDN | Burke Fred | See Remarks, Dir | M - OptEx | — | +1.30M | 1.30M | New | — |
| 2025-02-07 | 2025-02-05 | GRDN | Forbes Kendall | See Remarks | A - Grant | $0.00 | +10.4K | 10.4K | New | $0 | |
| 2025-02-07 | 2025-02-05 | GRDN | Morris David K | See Remarks, Dir | A - Grant | $0.00 | +10.4K | 10.4K | New | $0 | |
| 2024-11-20 | 2024-11-19 | GRDN | COSLER STEVEN D | Dir | P - Purchase | $21.22 | +7,000 | 17.7K | +65% | +$148.5K | |
| 2024-10-01 | 2024-09-27 | GRDN | Patchett Mary Sue | Dir | A - Grant | $0.00 | +3,571 | 7,142 | +100% | $0 | |
| 2024-10-01 | 2024-09-27 | GRDN | Patchett Mary Sue | Dir | P - Purchase | $14.00 | +3,571 | 3,571 | New | +$50.0K | |
| 2024-10-01 | 2024-09-27 | GRDN | LEWIS RANDALL J | Dir | P - Purchase | $14.00 | +3,571 | 3,571 | New | +$50.0K | |
| 2024-10-01 | 2024-09-27 | GRDN | LEWIS RANDALL J | Dir | A - Grant | $0.00 | +3,571 | 7,142 | +100% | $0 | |
| D | 2024-10-01 | 2024-09-27 | GRDN | Salentine Thomas J Jr | Dir | P - Purchase | $14.00 | +35.7K | 35.7K | New | +$500.0K |
| 2024-10-01 | 2024-09-27 | GRDN | COSLER STEVEN D | Dir | P - Purchase | $14.00 | +7,142 | 7,142 | New | +$100.0K | |
| 2024-10-01 | 2024-09-27 | GRDN | COSLER STEVEN D | Dir | A - Grant | $0.00 | +3,571 | 10.7K | +50% | $0 |
Purchase Sale Sale after option exercise All abbreviations